BioDelivera

Active

Programmable drug delivery precisely targets only diseased cells

What it does

BioDelivera has developed proprietary GCV™, a drug delivery platform designed to travel through the body and selectively target diseased cells while sparing healthy ones. GCVs can carry genetic medicines, DNA, RNA, small molecules, or combinations of these at the same time. BioDelivera has demonstrated efficacy in tumors, muscle, and brain and is expanding to additional tissues. The company’s mission is to enable cures for every patient, across every disease.

Its site says now · captured 2026-11-09

BioDelivera | Programmable drug delivery

BioDelivera is developing Guided Chimeric Vehicles (GCV™) to solve biotech’s biggest bottleneck: drug delivery.